Organovo Holdings (STU:4OR1) 3-Year Revenue Growth Rate : -50.10% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Organovo Holdings 3-Year Revenue Growth Rate?

Organovo Holdings's Revenue per Share for the three months ended in Dec. 2023 was €0.00.

During the past 12 months, Organovo Holdings's average Revenue per Share Growth Rate was -85.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was -50.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Organovo Holdings was 102.60% per year. The lowest was -50.10% per year. And the median was -16.00% per year.

Competitive Comparison of Organovo Holdings's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Organovo Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organovo Holdings's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Organovo Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Organovo Holdings's 3-Year Revenue Growth Rate falls into.

Organovo Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Organovo Holdings (STU:4OR1) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Organovo Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Organovo Holdings (STU:4OR1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (STU:4OR1) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ONVO:USA

Address

11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121

Website

https://www.organovo.com

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Organovo Holdings (STU:4OR1) Headlines

No Headlines